INTRODUCTION
In eukaryotic cells, chromatin structure and posttranslational modification of histone proteins play central roles in regulating gene expression. This is exemplified in animals where polycomb group proteins function as chromatin-based transcriptional repressors through their capacity to catalyze histone modifications and form higher order chromatin structures (recently reviewed in Schwartz and Pirrotta, 2013; Simon and Kingston, 2013) . Loss of polycomb protein function in Drosophila leads to abnormal body plan specification and in vertebrates polycomb orthologs are essential for normal embryonic development. Polycomb proteins are also perturbed in a range of cancers, suggesting that the polycomb system is critical for maintenance of normal cell identity (Bracken and Helin, 2009) .
Polycomb proteins are generally found in one of two protein complexes, the polycomb repressive complexes 1 or 2 (PRC1 or PRC2). In mammals, the catalytic core of PRC2 is comprised of EZH1 or EZH2, which trimethylate histone H3 on lysine 27 (H3K27me3) (Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Mü ller et al., 2002) . A series of auxiliary proteins, including SUZ12 and EED, associate with EZH1/2 and modulate targeting, chromatin binding, and catalytic activity (Cao and Zhang, 2004; Ketel et al., 2005; Margueron et al., 2009; Pasini et al., 2004) . In contrast, PRC1 monoubiquitylates histone H2A on lysine 119 (H2AK119ub1) (de Napoles et al., 2004; Wang et al., 2004a) . The catalytic core of PRC1 consists of RING1A or RING1B, which dimerize with one of six PCGF protein partners (PCGF1-6) that regulate assembly of specific PRC1 complexes (Buchwald et al., 2006; Chamberlain et al., 2008; Farcas et al., 2012; Gao et al., 2012; Gearhart et al., 2006; Li et al., 2006; Ogawa et al., 2002; Sá nchez et al., 2007) . Together, the combined activities of PRC1 and PRC2 are thought to be essential for normal polycomb-mediated transcriptional repression and developmental gene regulation (recently reviewed in Simon and Kingston, 2013) . Nevertheless, the molecular mechanisms by which polycomb group proteins recognize their target sites and initiate repressive chromatin domains remain poorly defined.
Molecular and functional characterization of the polycomb repressive complexes has revealed that they do not function independently (Bracken et al., 2006; Ku et al., 2008; Papp and Mü ller, 2006; Schwartz et al., 2006) . Instead, H3K27me3 placed by PRC2 is recognized by PRC1 complexes that contain chromobox (CBX) proteins (Cao et al., 2002; Min et al., 2003; Wang et al., 2004b) . Based on these initial observations, the prevailing view over the past decade has been that PRC1 is recruited in a hierarchical manner to sites with pre-existing PRC2 activity and H3K27me3. However, it has recently emerged that CBX proteins are in direct competition with two additional factors, RYBP/ YAF2, for a mutually exclusive binding site on RING1A/B (Wang et al., 2010) . Significantly, H3K27me3-binding CBX proteins are limited to canonical PRC1 complexes containing either PCGF2 (MEL18) or PCGF4 (BMI1) and the Polyhomeotic proteins (PHC1/2/3) (Gao et al., 2012; Levine et al., 2002) , while all PCGF proteins interact with RYBP/YAF2 to form variant PRC1 complexes lacking CBX proteins (Farcas et al., 2012; Gao et al., 2012; Gearhart et al., 2006; Lagarou et al., 2008; Sá nchez et al., 2007; Tavares et al., 2012) (Figure 1A ). The identification of variant PRC1 complexes and the observation that RING1B can occupy many of its target sites in the absence of H3K27me3 suggests that the hierarchical recruitment mechanism cannot explain all PRC1 complex targeting (Schoeftner et al., 2006; Tavares et al., 2012) . Therefore, the central principles that underpin recognition of polycomb target sites in vivo and the molecular chain of events that leads to the formation of polycomb domains integrating both PRC1 and PRC2 activity remain unclear.
In this study, we utilize a de novo targeting system and discover, contrary to expectation based on the proposed hierarchical recruitment mechanism, that binding of variant PRC1 complexes to chromatin is sufficient to initiate the formation of a polycomb domain containing PRC2 and H3K27me3. This activity is inherent to variant PRC1 complexes and relies on H2AK119ub1. Building on this striking observation, genetic ablation approaches in mouse embryonic stem cells (ESCs) reveal that deletion of PRC1 has dramatic genome-wide effects on PRC2 occupancy and H3K27me3. We further demonstrate that recognition of nonmethylated DNA by KDM2B, part of the PCGF1/PRC1 variant complex, is important for deposition of H2AK119ub1 and recruitment of PRC2 to a subset of CpG island targets and that this targeting activity is essential for normal mouse development. Together, these observations reveal a new PRC1-dependent logic for polycomb domain formation.
RESULTS
A System to Target PRC1 to Chromatin De Novo The hierarchical recruitment model posits that PRC2-dependent H3K27me3 is required to recruit canonical PRC1 complexes to chromatin. The recent demonstration that variant PRC1 complexes bind to many target sites, albeit at lower levels, independently of H3K27me3 suggests that PRC1 function may be more complex than previously envisaged (Tavares et al., 2012) . This new insight necessitates a more detailed examination of mammalian PRC1 complex function and targeting in vivo. Therefore, we sought to design a system in which individual PRC1 complexes could be targeted de novo to a chromatin environment free from the complexities and regulatory influences of natural polycomb target sites. To achieve this, a large bacterial artificial chromosome (BAC) containing human DNA that lacks identifiable genes and shows no evidence for gene-, enhancer-, or polycomb-associated chromatin modifications was selected and bacterial Tet operator (TetO) DNA-binding sites were centrally inserted ( Figure 1B) . Importantly, the TetO lacks CpG dinucleotides and has no resemblance to natural polycomb targets which are CpG-rich (Ku et al., 2008) . The TetO BAC was transposed into mouse ES cells at a site on chromosome 8, effectively flanking the TetO array with long stretches of inert chromatin ( Figures 1B, S1A , and S1B). Fusion of PRC1 components to the bacterial Tet repressor (TetR) DNA-binding domain would permit de novo recruitment to the TetO array ( Figure 1C ) and the direct consequences of fusion protein occupancy could be examined by chromatin immunoprecipitation (ChIP).
Variant PRC1 Complexes Place H2AK119ub1 and Recruit PRC2
In mammals, PCGF proteins (PCGF1-6) are thought to define the composition of individual PRC1 complexes and regulate their assembly and function ( Figure 1A ). To dissect how individual PRC1 complexes function on chromatin, PCGF1-5 were fused to TetR and stably expressed in the TetO cell line ( Figure 1C ). ChIP experiments revealed that TetR-PCGF fusion proteins bound the TetO array and diminished to background levels in flanking regions ( Figure 1D ). All PCGF proteins resulted in recruitment of RING1B, but surprisingly, only PCGF1, 3, and 5, which exclusively form variant PRC1 complexes (Farcas et al., 2012; Gao et al., 2012; Gearhart et al., 2006; Sá nchez et al., 2007) , placed significant levels of H2AK119ub1 ( Figure 1D ).
PRC1 and PRC2 largely occupy a common set of target sites in vivo (Ku et al., 2008; Papp and Mü ller, 2006; Schwartz et al., 2006; Tolhuis et al., 2006) , and this has been attributed to the hierarchical recruitment mechanism. Therefore, the possibility that PRC1 could potentially drive a reciprocal process and mediate PRC2 occupancy has not been specifically examined. By directly targeting individual PRC1 complexes to the TetO array, a unique opportunity existed to test whether PRC1 complexes can also drive PRC2 occupancy. Surprisingly, in the TetR-PCGF1, 3, and 5 fusion lines, ChIP analysis revealed binding of PRC2 components and H3K27me3 in regions flanking the TetO ( Figure 1E ). In contrast, TetR fusions with PCGF proteins that can form canonical PRC1 complexes (PCGF2 and 4) resulted in little, if any, PRC2 targeting and H3K27me3 ( Figure 1E ). Strikingly, variant complex-dependent PRC2 recruitment and H3K27me3 was also observed at a single naturally occurring TetO site in the mouse genome ( Figures S1C and S1D ), indicating that this is not unique to the engineered TetO array. Therefore, contrary to expectation based on the hierarchical recruitment mechanism, de novo recruitment of the PCGF 1, 3, and 5 variant PRC1 complexes results in the formation of a polycomb domain containing PRC2 and H3K27me3.
The Hierarchical PRC2-Dependent Recruitment of Canonical PRC1 Complexes Fails to Place H2AK119ub1 Surprisingly, PCGF proteins that form canonical PRC1 complexes appeared less competent at H2AK119ub1 placement in tethering assays ( Figure 1D ). This lack of activity could be inherent to canonical PRC1 complexes or possibly result from their covalent fusion to TetR. To circumvent the necessity to fuse canonical complexes to TetR, PRC2 was recruited to the TetO via a TetR-EED fusion (Figure 2A ) (Hansen et al., 2008) . This led to deposition of H3K27me3 and recruitment of endogenous PCGF2 and CBX7, but not PCGF1, suggesting PRC2-dependent recruitment of canonical PRC1 complexes ( Figure 2B ). As was the case with direct tethering of PCGF2 or 4, native canonical PRC1 complex nucleation failed to deposit H2AK119ub1, suggesting the lack of activity in canonical PRC1 tethering experiments does not result from TetR fusion ( Figure 2B) . Interestingly, the binding profiles for canonical PRC1 components were not completely coincident with H3K27me3, as might be expected if occupancy was entirely CBX dependent. It remains unclear why this disparity in profiles existed, but it may result from secondary structural effects driven by exclusive canonical PRC1 complex recruitment (Isono et al., 2013) or other undefined mechanisms involved in canonical PRC1 recruitment to regions containing PRC2 and H3K27me3. Interestingly, a similar discordance between CBX (PC) protein binding and H3K27me3 was observed at polycomb target sites in Drosophila cell culture models (Schwartz et al., 2006) . Nevertheless, this apparent failure of PRC2 and H3K27me3 to direct H2AK119ub1 parallels observations in mouse ESC lines devoid of H3K27me3 where levels of H2AK119ub1 at polycomb target sites are largely unaffected (Schoeftner et al., 2006; Tavares et al., 2012) . Together, these observations strongly suggest that PRC2-mediated recruitment of canonical PRC1 complexes fails to catalyze significant levels of H2AK119ub1.
Deposition of H2AK119ub1 Is Sufficient to Nucleate PRC2 and H3K27me3
The unexpected observation that variant PRC1 complexes can nucleate PRC2 to establish a polycomb domain de novo suggests that a feature associated with variant complex occupancy, perhaps H2AK119ub1, is responsible for this activity (Figure 1 ). To test this possibility, a single polypeptide fusion between the dimerization domains of RING1B and PCGF4 was engineered and fused to TetR (Bentley et al., 2011; Buchwald et al., 2006; Li et al., 2006) . This minimal RING1B/PCGF4 catalytic domain (RPCD) does not form normal PRC1 complexes ( Figure 3A ) but retains H2AK119ub1 E3 ligase activity ( Figure 3B ) (Cooper et al., 2014) leading to a striking enrichment of EZH2, SUZ12, and H3K27me3 at the TetO ( Figure 3B ). When mutations were engineered in TetR-RPCD (TetR-RPCDmut), rendering it incapable of catalyzing H2AK119ub1, PRC2 and H3K27me3 were no longer recruited to the TetO ( Figure 3B ). This suggests that H2AK119ub1, and not simply binding of PRC1 complexes, is the central determinant driving PRC1-dependent recruitment of PRC2.
Deletion of PRC1 and Loss of H2AK119ub1 Affects PRC2 Occupancy and H3K27me3 Genome-wide To examine the possibility that H2AK119ub1 may play a general role in PRC2 localization and activity at normal polycomb target sites, we exploited a Ring1a
Ring1b
fl/fl mouse ESC system, in which H2AK119ub1 can be rapidly depleted by removing the catalytic core of all PRC1 complexes (RING1A/B) through addition of the drug tamoxifen, without disrupting the cellular protein levels of PRC2 components (Figures 4A-4C ). Following RING1A/B deletion, ChIP-sequencing revealed a clear loss of SUZ12, EZH2, and H3K27me3 at individual genes (Figures 4D and S2A) and at target sites genome-wide ( Figure 4E and 4F). Indeed, 85% of SUZ12 and 83% of EZH2 sites showed a greater than 1.5-fold reduction in occupancy after PRC1 removal (Figures 4G and S3A) . A closer inspection of SUZ12 sites defined as having a less than 1.5-fold change in PRC2, revealed that these sites do exhibit an observable loss in PRC2 binding ( Figure S3B , S3C, and S3D) suggesting that most PRC2 sites are affected by loss of PRC1 activity. These effects on PRC2 occupancy were seemingly independent of high-level gene reactivation, as PRC2 reductions occurred at genes displaying small or large fluctuations in gene expression (Figures S2B and S2C) . Previous studies report that specific polycomb target sites rely on transcription factors or long noncoding RNAs (lncRNAs) for normal polycomb protein recruitment (Simon and Kingston, 2013) . In mouse ESCs the transcription factor REST (Arnold et al., 2013; Dietrich et al., 2012) and the Meg3 lncRNA (Kaneko et al., 2014) are thought to contribute to these targeting events. Interestingly, following PRC1 deletion, PRC2 occupancy was reduced at REST-occupied PRC2 sites ( Figure S3E ) and Meg3 lncRNA targets ( Figure S3F ), suggesting these mechanisms are insufficient to maintain normal levels of PRC2 and H3K27me3 in the absence of PRC1. Further segregation of PRC2 sites into those existing in a ''bivalent'' state containing H3K4me3 and H3K27me3 revealed that this subset of PRC2 sites had a slightly larger fold change in PRC2 occupancy following PRC1 deletion ( Figure S3G ). However, this difference was modest compared to the overall magnitude of PRC2 loss observed at both bivalent and nonbivalent sites. Unfortunately, it was not possible to examine whether longterm ablation of PRC1 activity would lead to a complete loss of PRC2 occupancy on chromatin, because mouse ESCs completely lacking PRC1 , unlike those lacking PRC2 (Boyer et al., 2006; Chamberlain et al., 2008; Leeb et al., 2010; Pasqualucci et al., 2011) , cannot be continuously maintained in culture. Under the conditional deletion conditions used here, some degree of residual PRC1 is evident ( Figure 4D , 4E, and S2A), and this may contribute to the remaining PRC2 occupancy. It should be noted, however, that PRC1-independent PRC2 targeting activities could also contribute to this residual PRC2 occupancy (Simon and Kingston, 2013) (see Discussion). Nevertheless, to examine in more detail the relationship between PRC1 loss and the resulting reduction in PRC2 occupancy, the fold change in PRC1 and PRC2 was compared at individual target sites genome-wide. This revealed a striking genome-wide correlation between the magnitude of PRC1 and PRC2 loss ( Figures 4H and S3H ), suggesting that (Farcas et al., 2012; He et al., 2013; Long et al., 2013; Wu et al., 2013) . Nonmethylated DNA is generally concentrated in vertebrate regulatory elements called CpG islands, and most mammalian polycomb target sites are associated with CpG islands (Ku et al., 2008) . KDM2B may therefore represent a direct molecular link between recognition of CpG island target sites and occupancy of both PRC1 and PRC2. To determine if KDM2B binding is sufficient to recruit the PCGF1/PRC1 complex and establish a polycomb domain de novo, a TetR-KDM2B fusion protein was stably expressed in the TetO cell line ( Figure 5A ). TetR-KDM2B led to RING1B, PCGF1, and H2AK119ub1 deposition ( Figure 5A ). This was not observed with the related KDM2A protein which does not interact with PRC1 ( Figure 5A ) (Blackledge et al., 2010) . Importantly, PCGF1/PRC1 recruitment by KDM2B resulted in binding of PRC2 and H3K27me3 ( Figures 5A and S4C ). This activity was dependent on recruitment of PCGF1/PRC1, as depletion of PCGF1 in the TetR-KDM2B line caused a clear reduction in both PRC1 and PRC2 ( Figures 5B and 5C ). Interestingly, polycomb domain formation did not rely on KDM2B demethylase activity, as a catalytic mutant of KDM2B or a short form of the protein that lacks the demethylase domain recruited PRC1 and PRC2 to similar levels ( Figures S4A-S4C ). Therefore, de novo targeting of the PCGF1/PRC1 complex by KDM2B leads to polycomb domain formation in a manner similar to TetR-PCGF1 (Figure 1) .
A System to Inducibly Ablate Targeting of the Variant PCGF1/PRC1 Complex by KDM2B
The observation that KDM2B can nucleate PRC1 and PRC2 provided an opportunity to examine whether targeting of the PCGF1/PRC1 variant complex to natural CpG island target sites is important for polycomb domain formation. To achieve this, a novel genetic system was designed in which an exon that encodes most of the KDM2B ZF-CxxC domain and is shared by both the long and short form of the protein ( Figures S4 and  S5A ) (Fukuda et al., 2011) was flanked by loxP sites (Kdm2b fl/fl ) ( Figure 5D ). Homozygous Kdm2b fl/fl mouse ESC lines were then derived that also stably express a tamoxifen-inducible form of Cre-recombinase. Addition of tamoxifen rapidly yielded KDM2B long and short form proteins that lack the ZF-CxxC domain ( Figures 5E and S5B ), but remain associated with the PCGF1/PRC1 variant complex ( Figure S5D ). Importantly, cellular levels of PRC1 and PRC2 components were unaffected (Figure S5C) . ChIP-seq for KDM2B in the Kdm2b fl/fl cells revealed KDM2B occupancy at CpG islands as previously described (Figure 5F) (Farcas et al., 2012; He et al., 2013; Wu et al., 2013) . However, tamoxifen-mediated deletion of the ZF-CxxC domain caused a near complete loss of KDM2B chromatin occupancy and removal of PCGF1 from CpG islands ( Figures 5F and 5G) . Therefore, deletion of the KDM2B ZF-CxxC domain is sufficient to ablate normal targeting of the PCGF1/PRC1 complex in vivo. Figures 6A-6D ). Of the 3,488 high-confidence RING1B peaks identified in ESCs, 43% showed a greater than 1.5-fold reduction in RING1B occupancy after tamoxifen treatment ( Figure 6D ), suggesting that a subset of RING1B-bound CpG islands is most sensitive to KDM2B loss, and other PRC1 complexes must contribute to RING1B occupancy at the remaining sites. Importantly, sites exhibiting RING1B loss also showed reduced H2AK119ub1 levels, consistent with a role for PCGF1/PRC1 in catalyzing this modification ( Figure 6I ). When SUZ12 ChIP-seq was carried out in the Kdm2b fl/fl and tamoxifen treated cells, there was a striking reduction of SUZ12 occupancy which broadly corresponded to the reduction in RING1B (Figures 6A-6D) . Indeed, 84% of SUZ12 peaks showing a greater than 1.5-fold reduction in SUZ12 binding overlapped with RING1B peaks (Figure 6D ), and 78% of these regions were associated with a greater than 1.5-fold reduction in RING1B binding. This again suggests an intimate relationship between loss of KDM2B-mediated PCGF1/PRC1 targeting and PRC2 occupancy. To examine this more closely, the relative change in the levels of RING1B and SUZ12 were directly compared ( Figures 6E and 6F) . Strikingly, as with the 
Ring1a
À/À Ring1b fl/fl system, the magnitude of RING1B and SUZ12 loss correlated well ( Figure 6F ), suggesting a direct relationship between PRC1 and PRC2 occupancy. Sites showing PRC2 loss also showed lower H3K27me3 levels ( Figure 6I ) and reduced binding of the canonical PRC1 complex component PCGF2 ( Figure 6I ). Interestingly, following loss of PCGF1/PRC1 targeting, genes with decreased RING1B occupancy exhibited only a very modest upregulation of average gene expression when analyzed by RNA-seq ( Figures 6C and 6G) , and the magnitude of RING1B loss and gene expression change showed little correlation ( Figures 6H, 6I, and 6J ). This supports a model whereby direct targeting of PRC1 to target sites in vivo contributes to the occupancy of PRC2, independently of large changes in gene expression.
Disruption of PCGF1/PRC1 Targeting Leads to Axial Skeletal Transformations and Embryonic Lethality in Mice
Perturbation of Ring1a or Ring1b in mice causes axial skeletal transformations (del Mar Lorente et al., 2000; Suzuki et al., 2002) due to defects in Hox gene expression, while deletion of Ring1b alone or both Ring1a and Ring1b leads to embryonic lethality (Posfai et al., 2012; Voncken et al., 2003) . To understand how PCGF1/PRC1 targeting affects development, mice hemizygous for loss of the KDM2B ZF-CxxC domain were generated by crossing Kdm2b fl/fl mice to a mouse constitutively expressing
Cre-recombinase. Initial observations suggested that loss of the KDM2B ZF-CxxC domain was semi-lethal as few heterozygous mice were recovered. When Kdm2b wt/DCxxC were mated to wild-type mice only 20% of offspring at 10 days postnatal (dpn) were Kdm2b wt/DCxxC , suggesting partial haploinsufficiency ( Figure 7A ). To examine if the Kdm2b wt/DCxxC mice exhibited homeotic transformations, skeletal preparations from newborn (n = 10) and 11 dpn (n = 2) Kdm2b wt/DCxxC mice were compared to control Kdm2b wt/wt mice. All of the Kdm2b wt/DCxxC heterozygous animals exhibited skeletal alterations with homeotic transformations in cervical to sacral regions ( Figures 7B and 7C) . Notably, seven of the ten newborn and both of the 11 dpn Kdm2b wt/DCxxC mice had extra bony elements at vertebrae C7, suggesting partial transformation into T1 (Kondo and Duboule, 1999) . While the second thoracic vertebra (T2) usually has a dorsal process, two of the newborn heterozygotes showed a dorsal process at T1 suggesting T1 to T2 transformation. Furthermore, dorsal processes were absent from T2 in six newborn and both 11 dpn heterozygotes, suggesting transformation of T2 to T3. Finally, two of the newborn heterozygotes showed L6-S1 transformations. Together, these homeotic phenotypes indicate posterior transformation of the vertebral column and phenocopy classical polycomb mutations (Akasaka et al., 1996; van der Lugt et al., 1994) . Attempts to generate Kdm2b DCxxC/DCxxC mice yielded no viable offspring. An initial examination of the embryonic defects in Kdm2b DCxxC/DCxxC embryos at 9 days postcoitum (dpc) suggested that development ceased at around 7 to 8 dpc in five of the embryos and two further embryos were composed only of extraembryonic tissues ( Figure 7D ). These phenotypes are much more severe than those previously reported for a Kdm2b mutant mouse (Fukuda et al., 2011) . However, in this previous study, only the long form of KDM2B was disrupted, while the short form of KDM2B, which can still target the PCGF1/PRC1 complex ( Figure S4 ) was unperturbed. Therefore, complete ablation of PCGF1/PRC1 targeting by removal of the ZF-CxxC domain from both KDM2B isoforms reveals that this activity is essential for normal development.
DISCUSSION
The co-occupancy of polycomb group proteins at target sites has largely been viewed in the context of a hierarchical recruitment model (Cao et al., 2002; Wang et al., 2004b) . Although this mechanism is clearly relevant for RING1B accumulation on chromatin, the singularity of the hierarchical recruitment pathway has recently been challenged by a series of observations in mammals demonstrating that PRC1 occupancy and H2AK119ub1 can be achieved in the absence of PRC2 (Pasini et al., 2007; Schoeftner et al., 2006; Tavares et al., 2012) and observations in Drosophila suggesting that H3K27me3 is not sufficient to recruit PRC1 complexes (Schwartz et al., 2006) . We now unexpectedly discover that variant, but not canonical, PRC1 complex occupancy leads to binding of PRC2 and placement of H3K27me3 in an H2AK119ub1-dependent manner, with deletion of the catalytic core of PRC1 in mouse ESCs resulting in a dramatic reduction in PRC2 and H3K27me3 at target sites. Furthermore, KDM2B-mediated targeting of the variant PCGF1/PRC1 complex to CpG islands is required for normal PRC2 levels at a subset of target sites and failure to target PCGF1/PRC1 results in polycomb phenotypes and embryonic lethality in mice. This provides an alternative to the hierarchical recruitment mechanism, effectively demonstrating that PRC1 complexes are not simply subservient readers of PRC2 activity but can instead be actively recruited to target sites and act as central players in polycomb domain formation. H2AK119ub1 levels are unaffected in ESCs lacking PRC2 (Schoeftner et al., 2006; Tavares et al., 2012) and disruption of canonical PRC1-complex-specific subunits in Drosophila cell culture does not significantly affect H2A ubiquitylation (Lagarou et al., 2008) . This is consistent with the failure of canonical PRC1 complexes to place H2AK119ub1 in tethering experiments (Figure 1) . Therefore, despite their competence to catalyze H2AK119ub1 in vitro (Gao et al., 2012; Tavares et al., 2012) , canonical complexes do not seem to play a major role in H2AK119ub1 deposition in vivo. This apparent discrepancy may result from a subunit specific to canonical PRC1 complexes that limits RING1A/B E3 ligase activity in cells, as a minimal catalytic fusion of PCGF4 and RING1B that does not interact with other canonical PRC1 complex proteins was competent to catalyze H2AK119ub1 (Figure 3) , whereas the intact canonical PCGF4/PRC1 complex appeared largely inactive (Figure 1) . A candidate for this inhibitory activity may be the vertebrate polyhomeotic orthologs (PHC1/2/3), which are specific to canonical PRC1 complexes. PHC proteins have been shown to self-associate via their sterile alpha motif (SAM) to organize polycomb domains in vivo (Isono et al., 2013; Kim et al., 2002) . It is tempting to speculate that the hierarchical recruitment pathway may largely function to drive PHC proteins to sites that have already acquired a polycomb domain and impose further alterations in chromatin structure.
The unexpected discovery that H2AK119ub1 plays a critical role in PRC2 occupancy and H3K27me3 at target sites appears at odds with observations in mouse ESCs lacking RING1B where PRC2 function appeared less affected (Eskeland et al., 2010; Leeb et al., 2010; van der Stoop et al., 2008) . However, RING1B null cells express RING1A and retain significant levels of H2AK119ub1 (Eskeland et al., 2010 ), suggesting that the relative level of H2AK119ub1 may be important for PRC2 occupancy. Importantly, PRC1 activity appears to drive PRC2 occupancy in other nonstereotypical examples of polycomb domain formation, suggesting this activity is not limited by genomic location (Cooper et al., 2014) . A future challenge remains to understand the molecular determinants that link H2AK119ub1 and PRC2 binding.
It is a commonly held view that mammalian polycomb proteins, under the guidance of site-specific DNA binding transcription factors or lncRNAs, are targeted to specific genes where they direct transcriptional repression (discussed in Simon and Kingston, 2013) . In stark contrast to site-specific targeting factors, KDM2B binds broadly to promoter-associated CpG islands through its nonmethylated DNA-binding activity, occupying genes covering the complete expression spectrum (Farcas et al., 2012; He et al., 2013; Wu et al., 2013) . Given the capacity of KDM2B to bind CpG islands, target the PCGF1/PRC1 variant complex, and initiate polycomb domains de novo, it is surprising that only a subset of the most repressed CpG island-associated genes accumulate polycomb proteins. A possible explanation for this somewhat paradoxical observation could be that counteracting chromatin features associated with transcription are sufficient to inhibit polycomb protein activity and that KDM2B/ PCGF1/PRC1 occupancy functions mainly as a sampling module to identify sites that lack transcription and facilitate initiation of a polycomb domain Ku et al., 2008; Lynch et al., 2012; Voigt et al., 2013) . Viewed in this context, one would predict that polycomb domain formation would not directly drive gene repression, but may instead function to limit stochastic or inappropriate reactivation of genes that have already been transcriptionally silenced. Consistent with these ideas, it was recently demonstrated through an elegant set of kinetic experiments in mammalian cell culture systems that polycomb chromatin modifications are mainly acquired at target sites after transcriptional silencing has been achieved (Hosogane et al., 2013; Yuan et al., 2012) . This agrees with the more general observation that loss of polycomb proteins in ESCs leads to reactivation of only a subset of all genes that are heavily occupied by polycomb proteins . In agreement with these general principles, loss of PCGF1/PRC1 targeting and its capacity to form polycomb domains did not lead to extensive gene reactivation (Figure 6 ).
It is clear that variant PRC1 complexes can drive de novo PRC2 occupancy (Figure 1) , and PRC1 is required for normal polycomb domain formation (Figure 4) . A variant PRC1 complex-driven sampling model could provide a simple and flexible solution for polycomb domain initiation and formation, but it should be made clear that our observations do not exclude potential contributions from PRC1-independent PRC2 targeting events. Following PRC1 deletion, there was a reduction, but not a complete loss, of PRC2 and H3K27me3 (Figure 4 ). While residual PRC1 binding or epigenetic maintenance of preexisting PRC2 could be responsible for this, previously reported PRC1-independent targeting mechanisms could also play a central role in remaining PRC2 occupancy (Simon and Kingston, 2013) . Viewed in this light, it remains possible that PRC1 and PRC2 are recruited to target sites independently and then function to mutually sustain and stabilize their respective binding. A better understanding of the molecular mechanisms that underpin polycomb protein targeting will help to further define the relationship between PRC1 and PRC2 on chromatin. (D) Kdm2b homozygous null embryos recovered at 9 dpc exhibited severe developmental delay (n = 5) or in some cases only extraembryonic development (n = 2) (representative examples are shown in center and right, respectively). A heterozygote sibling is shown to indicate expected development at this stage (left).
Cancer-exome-sequencing endeavours have recently revealed that core components of the KDM2B/PRC1 complex, including KDM2B itself and BCOR/L1, are frequently mutated in a range of cancers, particularly leukemias (Brookes et al., 2012; Grossmann et al., 2011; Pasqualucci et al., 2011; Zhang et al., 2012) . Given the essential nature of polycomb protein function in vertebrate development and its implication in human pathology, our fundamental discovery that PRC1 activity plays an important role in normal PRC2 occupancy provides an unexpected new perspective on the principles that underpin polycomb domain formation. Furthermore, toward addressing the central yet poorly understood question of defining how polycomb sites are established in vivo, we provide evidence that, at least in some cases, there may exist a relatively simple molecular chain of events whereby KDM2B-mediated recognition of nonmethylated DNA at receptive CpG islands leads to recruitment of PRC1 and deposition of H2AK119ub1 that ultimately translates into occupancy of PRC2 necessary for normal placement of H3K27me3.
EXPERIMENTAL PROCEDURES
Generation of the De Novo Targeting System A TetO array comprising 14 TetO sites interspersed by random CpG-free 21 bp sequences was seamlessly recombineered into BAC RP11 419E6. Tol2 sequence elements were then recombineered into the plasmid backbone portion of the BAC, together with a neomycin resistance cassette. Using Lipofectamine 2000 (Life Technologies) the TetO BAC was cotransfected with a Tol2 transposase expression plasmid into E14 mouse ESCs, and stable G418 (400 mg/ml) resistant clones were obtained. A PCR screen was used to identify a clone exhibiting Tol2-mediated integration and splinkerette PCR was used to map the precise BAC integration site on mouse chromosome 8.
The TetR coding sequence was inserted into a modified pCAG-IRES-Puro mammalian expression plasmid, between the coding sequence for an N-terminal FLAG STREPx2 (FS2) tag and a 3 0 ligation-independent cloning (LIC) site.
The resultant plasmid was named pCAGFS2TetR. Coding sequences for proteins of interest were inserted into pCAGFS2TetR by LIC cloning. All plasmids were transfected into the TetO BAC-containing ESCs and stable clones expressing TetR fusion proteins were obtained by selection with puromycin (1 mg/ml). TetR fusion proteins were detected in ChIP experiments using an FS2-specific antibody. Other details of the TetR targeting system are described in Extended Experimental Procedures.
Chromatin Immunoprecipitation
ChIP was performed as described previously (Farcas et al., 2012) , with minor modifications. Briefly, for nonhistone ChIP cells were fixed for 1 hr in 2 mM EGS, followed by 15 min in 1% formaldehyde, while for histone modification ChIP cells were fixed for 10 min in 1% formaldehyde alone. Cells were sequentially lysed and sonication was performed to produce fragments of approximately 0.5-1 kb. Immunoprecipitation was performed overnight at 4 C with approximately 3 mg of antibody. Antibody-bound chromatin was isolated on protein A beads, washed extensively and purified as described in Extended Experimental Procedures.
Gene Expression Analysis
For RNA-seq analysis, polyA+ RNA was purified from total RNA and then a directional library was prepared using the NEBNext Ultra Directional RNA library Prep Kit for Illumina (NEB, Ipswich, MA).
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